Karin Allenspach Selected Research

Karin Allenspach Research Topics

Disease

22	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 05/2021 - 09/2004
6	Inflammation (Inflammations) 01/2021 - 02/2010
5	Protein-Losing Enteropathies (Protein-Losing Enteropathy) 05/2021 - 10/2008
3	Neoplasms (Cancer) 01/2021 - 11/2017
3	Diarrhea 01/2021 - 01/2008
2	Chronic Disease (Chronic Diseases) 01/2022 - 01/2021
2	Intestinal Diseases (Diseases, Intestinal) 01/2021 - 01/2019
2	HIV Infections (HIV Infection) 03/2015 - 06/2014
2	Infections 01/2015 - 09/2012
1	Urinary Bladder Neoplasms (Bladder Cancer) 01/2021
1	Alzheimer Disease (Alzheimer's Disease) 01/2021
1	Atrophy 01/2021
1	Gastrointestinal Diseases (Functional Gastrointestinal Disorders) 01/2021
1	Colorectal Neoplasms (Colorectal Cancer) 01/2021
1	Thrombophilia 01/2021
1	Cognitive Dysfunction 01/2021
1	Obesity 01/2020
1	Vitamin D Deficiency 01/2020
1	Ulcerative Colitis 07/2019
1	Hematologic Neoplasms (Hematological Malignancy) 01/2019
1	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2019
1	Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor) 11/2018
1	Lymphoma (Lymphomas) 01/2018
1	Cystic Fibrosis (Mucoviscidosis) 12/2017
1	Porcine Reproductive and Respiratory Syndrome (PRRS) 11/2017
1	Disease Susceptibility (Diathesis) 01/2015
1	Disease Progression 01/2015
1	Hemolytic Anemia 09/2012
1	Pancreatitis 06/2009

Drug/Important Bio-Agent (IBA)

5	Biomarkers (Surrogate Marker)IBA 01/2021 - 03/2011
5	CytokinesIBA 01/2021 - 02/2010
5	Proteins (Proteins, Gene)FDA Link 01/2020 - 10/2008
3	Messenger RNA (mRNA)IBA 01/2021 - 01/2018
3	Tryptophan (L-Tryptophan)FDA Link 01/2021 - 01/2019
2	Pharmaceutical PreparationsIBA 01/2022 - 01/2021
2	SteroidsIBA 05/2021 - 01/2019
2	Phenobarbital (Luminal)FDA Link 01/2021 - 12/2008
2	PrebioticsIBA 01/2020 - 03/2016
2	Anti-Bacterial Agents (Antibiotics)IBA 01/2019 - 10/2018
2	Antiviral Agents (Antivirals)IBA 03/2015 - 06/2014
2	AutoantibodiesIBA 09/2012 - 10/2008
1	STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA 05/2021
1	Biological ProductsIBA 01/2021
1	Amyloid (Amyloid Fibrils)IBA 01/2021
1	AntigensIBA 01/2021
1	Cholecalciferol (Vitamin D3)FDA Link 01/2021
1	KynurenineIBA 01/2021
1	MonosaccharidesIBA 01/2021
1	Serotonin (5 Hydroxytryptamine)IBA 01/2021
1	Amyloid beta-PeptidesIBA 01/2021
1	MicroRNAs (MicroRNA)IBA 02/2020
1	Immunologic Factors (Immunomodulators)IBA 01/2020
1	Vitamin D FDA LinkGeneric 01/2020
1	GlycosaminoglycansIBA 01/2020
1	Bile Acids and Salts (Bile Acids)IBA 01/2019
1	PyrrolesIBA 01/2019
1	Chimeric Antigen ReceptorsIBA 01/2019
1	GlucocorticoidsIBA 01/2019
1	toceranib phosphateIBA 11/2018
1	Immunosuppressive Agents (Immunosuppressants)IBA 10/2018
1	Amino Acids FDA Link 05/2018
1	Pathogen-Associated Molecular Pattern MoleculesIBA 11/2017
1	Transcription Factors (Transcription Factor)IBA 11/2017
1	Pattern Recognition ReceptorsIBA 11/2017
1	GlucansIBA 03/2016
1	Resistant StarchIBA 03/2016
1	Chondroitin Sulfates (Chondroitin Sulfate)IBA 03/2016
1	InflammasomesIBA 01/2015
1	Toll-Like Receptors (Toll-Like Receptor)IBA 01/2015
1	Interleukin-22 (IL-22)IBA 01/2015
1	Interleukin-17 (Interleukin 17)IBA 01/2015
1	ThiazinesIBA 06/2014
1	S100A12 ProteinIBA 04/2014
1	Trefoil FactorsIBA 01/2013
1	FlagellinIBA 01/2012
1	NF-kappa B (NF-kB)IBA 02/2010
1	Lipase (Acid Lipase)FDA Link 06/2009
1	AntibodiesIBA 09/2004

Therapy/Procedure

3	Therapeutics 01/2019 - 01/2008
1	Drug Therapy (Chemotherapy) 01/2021
1	Remission Induction 01/2021
1	Immunotherapy 01/2019
1	Transplantation 12/2017
1	Aftercare (After-Treatment) 03/2006